InvestorsHub Logo
Followers 26
Posts 1051
Boards Moderated 0
Alias Born 07/31/2001

Re: None

Sunday, 07/22/2018 2:59:25 PM

Sunday, July 22, 2018 2:59:25 PM

Post# of 403528
Is IPIX the real deal? You bet! Not only is the FDA going through the motions of advancing our drugs to the next trial level, they are doing so with add-ons that are reserved for only the best of the best in their view.

sox040713 Friday, 02/02/18 01:47:07 PM
Re: None 0
Post # of 235037

"Special designations, such as Fast Track, Priority Review and Orphan Drug status, are awarded by the FDA to companies with particularly promising drugs under development. Innovation has received various FDA designations, reinforcing the potential of the company’s pipeline, while also providing better odds of a drug candidate's expedited approval, often with added exclusivity protections. Almost three-in-four drugs (73%) approved by the FDA in the U.S. in 2016 received some form of expedited development and review, with one-in-three (36%) representing first-in-class status.”

http://www.ipharminc.com/special-fda-designations/

IPIX Drug Designations

1. B-OM - Fast Track
2. B-ABSSSI - QIDP (first-in-class)
3. K-OC - Orphan Drug
4. P - 505(b)(2)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News